Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial

INTRODUCTION: The relationship between sodium glucose co-transporter 2 inhibitors (SGLT2i) and trimethylamine N-oxide (TMAO) following acute myocardial infarction (AMI) is not yet explored. METHODS: In this secondary analysis of the EMMY trial (ClinicalTrials.gov registration: NCT03087773), changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Faisal, Tripolt, Norbert J., Pferschy, Peter N., Kolesnik, Ewald, Mangge, Harald, Curcic, Pero, Hermann, Markus, Meinitzer, Andreas, von Lewinski, Dirk, Sourij, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357596/
https://www.ncbi.nlm.nih.gov/pubmed/37475009
http://dx.doi.org/10.1186/s12933-023-01920-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357596/
https://www.ncbi.nlm.nih.gov/pubmed/37475009
http://dx.doi.org/10.1186/s12933-023-01920-6

Ejemplares similares